17 January 2020 | News
Metropolis Healthcare Ltd, the leading pan-India ‘pathology specialist’, has signed a binding agreement to acquire Ahmedabad based Shraddha Diagnostics Pvt Ltd
image credit- shuttershock.com
Metropolis Healthcare Ltd, the leading pan-India ‘pathology specialist’, has signed a binding agreement to acquire Ahmedabad based Shraddha Diagnostics Pvt Ltd.
With this acquisition, Metropolis has expanded its lab footprint from 17 to 20 in nine cities and towns of Gujarat; Ahmedabad, Surat, Baroda, Mehsana, Rajkot, Navsari, Jamnagar, Bharuch and Gandhidham. Besides, presently, the company has 300 patient service network centres across Gujarat and services over 1500+ clients through its robust B2B network.
Ameera Shah, Promoter and Managing Director, Metropolis Healthcare Ltd said, “Gujarat has always been an important market for us. In October 2019, we acquired 4 laboratories in Surat that increased our market share and we are now leaders in the region. With the Ahmedabad acquisition, we are aiming to gain profitable market share by building better leadership, operational capabilities, and expanding our test menu. Our immediate focus would be to fully integrate and modernize these laboratories and in terms of diagnosis,
deliver on our promise of integrity, empathy, and accuracy.”
Shraddha Diagnostic Pvt Ltd was started by Dr. Hiren Shah and Dr. Dushyant Patel. With these two young and dynamic pathologists joining the Metropolis Family, it is the right launchpad for modern and integrated laboratory services in Ahmedabad. Metropolis has a track record of acquiring and successfully integrating companies by bringing in industry best practices to these acquired businesses including standardized machines and standard operating procedures, in a phased manner, resulting in efficiency and quality enhancement. Metropolis, since 2002 has successfully used its brand strength to established large networks through acquisitions in Chennai, Rajkot, Surat, Bangalore, Pune as well as outside India.